Correlation Between Cytosorbents Crp and Interpace Biosciences

Can any of the company-specific risk be diversified away by investing in both Cytosorbents Crp and Interpace Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytosorbents Crp and Interpace Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cytosorbents Crp and Interpace Biosciences, you can compare the effects of market volatilities on Cytosorbents Crp and Interpace Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytosorbents Crp with a short position of Interpace Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytosorbents Crp and Interpace Biosciences.

Diversification Opportunities for Cytosorbents Crp and Interpace Biosciences

0.07

Correlation Coefficient

Cytosorbents Crp  Interpace Biosciences

Significant diversification

The 3 months correlation between Cytosorbents and Interpace is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Cytosorbents Crp and Interpace Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Interpace Biosciences and Cytosorbents Crp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytosorbents Crp are associated (or correlated) with Interpace Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Interpace Biosciences has no effect on the direction of Cytosorbents Crp i.e., Cytosorbents Crp and Interpace Biosciences go up and down completely randomly.

Pair Corralation between Cytosorbents Crp and Interpace Biosciences

Given the investment horizon of 90 days Cytosorbents Crp is expected to under-perform the Interpace Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Cytosorbents Crp is 1.04 times less risky than Interpace Biosciences. The stock trades about -0.01 of its potential returns per unit of risk. The Interpace Biosciences is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  80.00  in Interpace Biosciences on July 8, 2025 and sell it today you would earn a total of  4.00  from holding Interpace Biosciences or generate 5.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cytosorbents Crp  vs.  Interpace Biosciences

Cytosorbents Crp

Risk-Adjusted Performance

Weakest

Over the last 90 days Cytosorbents Crp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Cytosorbents Crp is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Interpace Biosciences

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Interpace Biosciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Interpace Biosciences reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cytosorbents Crp and Interpace Biosciences

The main advantage of trading using opposite Cytosorbents Crp and Interpace Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytosorbents Crp position performs unexpectedly, Interpace Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Interpace Biosciences will offset losses from the drop in Interpace Biosciences' long position.

The idea behind Cytosorbents Crp and Interpace Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.